Testing an oral drug for high Lp(a) and heart risk
Part of Heart & circulation clinical trials.
This trial tests whether a new once-daily pill called SAL0137 can safely lower Lp(a), a type of cholesterol that raises heart attack and stroke risk. It's for adults with high Lp(a) and other heart risk factors, like prior heart problems or diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have high Lp(a) — a blood test shows Lp(a) level of 150 nmol/L or more (or about 60 mg/dL).
- You are at increased risk for a heart attack or stroke (for example, you have heart disease, prior heart attack, or diabetes).
- Your body mass index (BMI) is between 18.5 and 40.
- You are on stable doses of your current heart medications (if any) and willing to take study pill daily.
- You agree to use effective birth control if needed, and are not pregnant or nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called SRSD216 for people with high levels of lipoprotein (a), a type of fat in the blood that can increase heart disease risk. The study aims to see if the drug is safe and effective at lowering these levels.
This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.
This study tests an oral medicine (HRS-5346) to lower lipoprotein(a), a type of fat in the blood linked to heart problems. It might help people with high levels who are at increased risk for heart attacks or strokes.
This trial tests a new drug called SAL0167 in healthy people to see if it is safe and how the body processes it. The study has two parts: Part A includes all healthy volunteers, and Part B focuses on people with moderately high cholesterol.
This trial tests a new drug called AZD4954 for safety. It includes healthy volunteers and people with high Lp(a) or dyslipidemia. The goal is to see if the drug is safe and how the body processes it.
This trial tests two experimental drugs designed to lower lipoprotein(a)—a type of cholesterol particle linked to heart disease—in people whose levels remain high despite taking statins (cholesterol-lowering medications). The goal is to see if these drugs can safely reduce this risk factor.
Hear when a new Elevated Lipoprotein(a) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.